Insider trading

Period: 120 months Stock: EXEL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

404 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

404 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

404 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

404 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
404 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
404 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

404 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
12 Feb 2021
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$970.65K 45,000 at 21.57
15.4%
1 Feb 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.44M 65,000 at 22.08
18.7%
12 Jan 2021
Senner Christopher J. EVP and CFO
Sold, plan not stated
$750.00K 30,000 at 25.00
10.9%
4 Jan 2021
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.32M 65,000 at 20.32
18.7%
18 Dec 2020
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.30M 65,000 at 20.01
18.7%
24 Nov 2020
Sold, plan not stated
$740.07K 40,004 at 18.50
30.7%
10 Nov 2020
Sold, plan not stated
$700.74K 34,000 at 20.61
14.7%
21 Oct 2020
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$872.34K 39,742 at 21.95
10.4%
8 Oct 2020
Senner Christopher J. EVP and CFO
Sold, plan not stated
$250.00K 10,000 at 25.00
7.3%
22 Sep 2020
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$268.14K 10,258 at 26.14
2.9%
21 Sep 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$122.10K 4,680 at 26.09
3.9%
16 Sep 2020
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$522.20K 20,000 at 26.11
5.5%
15 Sep 2020
Senner Christopher J. EVP and CFO
Sold, plan not stated
$500.00K 20,000 at 25.00
13.5%
20 Jul 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$79.91K 3,151 at 25.36
2.7%
8 Jun 2020
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$586.56K 26,000 at 22.56
17.0%
4 Jun 2020
Schwab Gisela Pres, Prod Dev & Med Aff & CMO
Sold, plan not stated
$2.30M 100,000 at 22.96
23.5%
22 May 2020
Garber Alan M Director
Sold, plan not stated
$881.83K 36,111 at 24.42
74.0%
Sold half or more
21 May 2020
Sold, plan not stated
$985.60K 40,000 at 24.64
30.7%
20 May 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$78.74K 3,151 at 24.99
2.7%
18 May 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$1.95M 75,000 at 25.96
9.5%
18 May 2020
WILLSEY LANCE Director
Sold, plan not stated
$787.80K 30,000 at 26.26
7.5%
14 May 2020
WILLSEY LANCE Director
Sold, plan not stated
$378.90K 15,000 at 25.26
3.9%
11 May 2020
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$1.03M 38,006 at 27.09
13.7%
11 May 2020
Sold, plan not stated
$789.00K 30,000 at 26.30
26.7%
8 May 2020
Senner Christopher J. EVP and CFO
Sold, plan not stated
$2.03M 78,583 at 25.81
39.4%
8 May 2020
Sold, plan not stated
$1.16M 45,000 at 25.84
4.1%
8 May 2020
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$651.00K 25,000 at 26.04
9.5%
8 May 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$552.97K 21,375 at 25.87
15.3%
7 May 2020
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$1.28M 50,000 at 25.54
28.3%
7 May 2020
FELDBAUM CARL B Director
Sold, plan not stated
$789.28K 31,546 at 25.02
78.7%
Sold half or more
7 May 2020
POSTE GEORGE Director
Sold, plan not stated
$768.30K 30,000 at 25.61
21.0%
7 May 2020
Hessekiel Jeffrey EVP and General Counsel
Sold, plan not stated
$768.30K 30,000 at 25.61
11.1%
7 May 2020
Senner Christopher J. EVP and CFO
Sold, plan not stated
$552.56K 21,417 at 25.80
15.1%
24 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$393.60K 15,000 at 26.24
2.0%
23 Apr 2020
Schwab Gisela Pres, Prod Dev & Med Aff & CMO
Sold, plan not stated
$2.60M 100,000 at 26.00
23.5%
23 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated 2×
$2.60M 100,000 at 25.99
11.7%
23 Apr 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$130.00K 5,000 at 26.00
4.1%
22 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$105.21K 4,200 at 25.05
0.5%
21 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$145.23K 5,800 at 25.04
0.7%
20 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated 3×
$1.19M 50,000 at 23.89
5.5%
20 Apr 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$120.00K 5,000 at 24.00
4.1%
15 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$457.75K 25,000 at 18.31
2.7%
8 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$129.64K 7,065 at 18.35
0.7%
7 Apr 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$299.94K 16,435 at 18.25
1.7%
6 Apr 2020
Lamb Peter EVP, Scientific Strategy & CSO
Sold, plan not stated
$863.00K 50,000 at 17.26
28.3%
3 Apr 2020
Sold, plan not stated
$229.46K 13,848 at 16.57
7.9%
31 Mar 2020
SCANGOS GEORGE A Director
Sold, plan not stated
$27.09K 1,500 at 18.06
0.2%
20 Mar 2020
Haley Patrick J. EVP, Commercial
Sold, plan not stated
$66.37K 4,318 at 15.37
3.6%
4 Mar 2020
Schwab Gisela Pres, Prod Dev & Med Aff & CMO
Sold, plan not stated 2×
$1.94M 100,000 at 19.40
23.5%
3 Mar 2020
FELDBAUM CARL B Director
Sold, plan not stated 2×
$716.01K 38,000 at 18.84
81.7%
Sold half or more
Showing 151–200 of 404. ← Newer Page 4 of 9 Older →